Metabolic Research Peptides
Next-generation peptides researched for metabolic pathways including appetite regulation, energy expenditure, and lipid metabolism. Retatrutide is the first triple-acting GIP/GLP-1/Glucagon agonist, AOD-9604 targets lipolysis via the GH pathway, and Cagrilintide acts through the amylin receptor.
Categories
Tags
Availability
-10%
Metabolic
AOD-9604
Modified hGH fragment (176-191) studied for fat metabolism and lipolysis research. Interacts with beta-3 adrenergic receptors without growth-promoting effects.
From
€49.99
€55.49
2 variants
-17%
Metabolic
Retatrutide
First-ever triple-action weight management peptide targeting three receptors at once: GIP, GLP-1, and glucagon. Shown exceptional results in Phase 2 trials - up to 24% weight reduction. The most advanced metabolic peptide available.
From
€149.99
€179.99
3 variants